Skip to content
PubMed This is a summary of 4 peer-reviewed journal articles Updated
Medical Genetics · Aagenaes Syndrome

Genetics and Interpreting the Lab Report

At a Glance

Aagenaes syndrome is supported by compatible infant cholestasis or related clinical features plus pathogenic or likely pathogenic variants in both copies of UNC45A. Testing must assess the 5'-UTR, and a genetics professional should interpret the report.

For many years, the cause of Aagenaes syndrome was a mystery. Today, advancements in genetic testing have provided a clear answer: a change in the UNC45A gene supports the diagnosis [1]. This discovery has transformed how we approach the condition, allowing families to get answers much earlier—often while their child is still an infant [1][2].

The Diagnosis: UNC45A

Aagenaes syndrome is an autosomal recessive disorder, meaning a child must inherit two altered copies of the UNC45A gene (one from each parent) to have the condition [1]. Diagnosis should be framed as a compatible clinical phenotype plus biallelic pathogenic or likely pathogenic UNC45A variants, with interpretation by a genetics professional.

While most standard genetic tests look at the “coding” parts of a gene—the parts that provide direct instructions for proteins—the primary cause of Aagenaes syndrome is often found in the 5’-UTR (5’-untranslated region) [1]. This is a “control region” of the gene that regulates how much protein is made. Make sure your doctor knows a standard coding-only panel may miss this common 5’-UTR variant.

  • The c.-98G>T or c.-88G>A Variants: These indicate the exact “address” of the genetic change. They act like a “dimmer switch,” significantly lowering the amount of UNC45A protein in the liver and lymphatic cells [1].
  • Homozygous vs. Compound Heterozygous: Your child’s report will likely use one of these two terms. Homozygous means they have the same variant (like c.-98G>T) on both copies of the gene. Compound heterozygous means they have two different variants—for example, the c.-98G>T variant on one copy and a different “loss-of-function” variant on the other [1][2].

Why Early Testing Matters

One of the most valuable roles of genetic testing is its ability to help establish a diagnosis of Aagenaes syndrome before lymphedema (leg swelling) even begins [1].

Because the liver symptoms usually appear first, doctors may order a neonatal cholestasis gene panel [3]. This is a single test that checks dozens of different genes known to cause liver issues in babies. If the test identifies the UNC45A variants alongside compatible symptoms, it supports that the baby has Aagenaes syndrome. This allows parents and doctors to know that leg swelling may develop later in childhood, rather than being surprised by it years down the road [1].

However, a biallelic UNC45A result does not replace urgent assessment for biliary atresia or other treatable causes of infant liver issues, which require rapid clinical, laboratory, and imaging work-up.

Distinguishing Aagenaes from “Look-Alikes”

There are other rare conditions that involve both liver issues and lymphedema, and genetic testing helps tell them apart.

The most common “look-alike” is Hennekam syndrome (also known as LCS2). While the symptoms may look similar, Hennekam syndrome is caused by mutations in the CCBE1 gene (or sometimes FAT4 or ADAMTS3) [4]. It often involves additional symptoms, such as unique facial features or intellectual disability, which are not typically part of Aagenaes syndrome [4]. Identifying the UNC45A variant helps confirm it is Aagenaes (LCS1) and not one of these other conditions.

Navigating the Lab Report

When you look at your child’s genetic report, it can be helpful to focus on these key areas:

  1. Gene Name: Look for UNC45A.
  2. Variant Description: You may see codes like c.-98G>T or c.-88G>A, which should be reported with the transcript and evidence for pathogenicity [1][2].
  3. Classification: Variants are usually labeled as Pathogenic (disease-causing) or Likely Pathogenic. If a variant is labeled as a Variant of Uncertain Significance (VUS), a single variant, or a negative test, it does not confirm the condition, and you should discuss this carefully with a genetic counselor [2].
  4. Testing the Parents: Doctors often recommend testing both parents (called “segregation testing”). This confirms that the child inherited one variant from each parent, which is the hallmark of an autosomal recessive diagnosis [1]. Genetic testing should be ordered or interpreted with a genetic counselor.

Common questions in this guide

How is Aagenaes syndrome confirmed by genetic testing?
Aagenaes syndrome is supported when a child has a compatible clinical pattern and pathogenic or likely pathogenic variants in both copies of the UNC45A gene. The variants should be interpreted by a genetics professional because a genetic result is part of the diagnosis rather than a substitute for clinical assessment.
Can a standard genetic panel miss the cause of Aagenaes syndrome?
Yes. The common UNC45A changes may be in the 5'-UTR, a control region outside the protein-coding part of the gene, so a coding-only panel may not detect them. Ask whether the test covered the full 5'-UTR and included the correct gene transcript.
What do c.-98G>T and c.-88G>A mean on the report?
These codes identify specific changes in the 5'-UTR of UNC45A. They can reduce the amount of UNC45A protein made in liver and lymphatic cells, but their significance should be confirmed from the report's transcript and laboratory classification.
What is the difference between homozygous and compound heterozygous?
Homozygous means the same UNC45A variant is present on both gene copies. Compound heterozygous means two different UNC45A variants are present, one on each copy; testing parents can help confirm how they were inherited.
Does a VUS or one UNC45A variant confirm Aagenaes syndrome?
No. A variant of uncertain significance, a single UNC45A variant, or a negative result does not by itself confirm Aagenaes syndrome. A genetic counselor can review whether the test covered the 5'-UTR and whether parental or additional testing is needed.
Why should both parents have genetic testing?
Parent testing, sometimes called segregation testing, can show whether the child inherited one UNC45A variant from each parent, which supports an autosomal recessive diagnosis. The results can also help the family discuss recurrence risk and future family planning with a genetics professional.
How can testing distinguish Aagenaes syndrome from Hennekam syndrome or biliary atresia?
Aagenaes syndrome is associated with disease-causing variants in both copies of UNC45A, while Hennekam syndrome is linked to CCBE1 and sometimes FAT4 or ADAMTS3. However, a biallelic UNC45A result does not replace prompt clinical, laboratory, and imaging evaluation for biliary atresia or other treatable causes of infant cholestasis.

Get notified when new evidence is published on Cholestasis-lymphedema syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (4)
  1. 1

    Aagenaes syndrome/lymphedema cholestasis syndrome 1 is caused by a founder variant in the 5'-untranslated region of UNC45A.

    Almaas R, Atneosen-Åsegg M, Ytre-Arne ME, et al.

    Journal of hepatology 2023; (79(4)):945-954 doi:10.1016/j.jhep.2023.05.037.

    PMID: 37328071
  2. 2

    A New Unc45a 5'utr Variant In Patients With Aagenaes Syndrome.

    Tan TT, Dogan YC, Yilmaz ZB, et al.

    American journal of medical genetics. Part A 2025; (197(6)):e64004 doi:10.1002/ajmg.a.64004.

    PMID: 39887522
  3. 3

    Diagnostic algorithm for neonatal intrahepatic cholestasis integrating single-gene testing and next-generation sequencing in East Asia.

    Hahn JW, Lee H, Shin M, et al.

    Journal of gastroenterology and hepatology 2024; (39(5)):964-974 doi:10.1111/jgh.16505.

    PMID: 38323732
  4. 4

    Angioid streaks in aagenaes syndrome.

    Shoumnalieva-Ivanova V, Tanev I, Zdravkov Y, et al.

    International ophthalmology 2017; (37(4)):1065-1068 doi:10.1007/s10792-016-0344-y.

    PMID: 27614462

This page explains UNC45A testing and Aagenaes syndrome lab reports for informational purposes only and does not constitute medical advice. Your child's genetic counselor and clinicians should interpret the report and arrange urgent evaluation of infant cholestasis when needed.